(Q38792012)

6 September 2017

Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients (English)

1 reference

6 September 2017

0 references

1

0 references

Steven Rosenberg

14

object named as

Steven A Rosenberg

1 reference

6 September 2017

Maria R Parkhurst

2

1 reference

6 September 2017

Eric Tran

3

1 reference

6 September 2017

Anna Pasetto

4

1 reference

6 September 2017

Paul F Robbins

5

1 reference

6 September 2017

Sadia Ilyas

6

1 reference

6 September 2017

Todd D Prickett

7

1 reference

6 September 2017

Jared J Gartner

8

1 reference

6 September 2017

Jessica S Crystal

9

1 reference

6 September 2017

Ilana M Roberts

10

1 reference

6 September 2017

Kasia Trebska-McGowan

11

1 reference

6 September 2017

John R Wunderlich

12

1 reference

6 September 2017

James C Yang

13

1 reference

6 September 2017

language of work or name

English

0 references

publication date

22 February 2016

1 reference

6 September 2017

1 reference

6 September 2017

22

1 reference

6 September 2017

4

1 reference

6 September 2017

433-438

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.4051

6 September 2017

0 references

cites work

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

1 reference

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

21 January 2018

1 reference

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors

21 January 2018

1 reference

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

21 January 2018

1 reference

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

21 January 2018

1 reference

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

21 January 2018

1 reference

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

21 January 2018

1 reference

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

21 January 2018

1 reference

Signatures of mutational processes in human cancer

21 January 2018

1 reference

21 January 2018

Cancer genome landscapes

1 reference

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

21 January 2018

1 reference

Genetic basis for clinical response to CTLA-4 blockade in melanoma

21 January 2018

1 reference

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

21 January 2018

1 reference

Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.

21 January 2018

1 reference

Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

21 January 2018

1 reference

Neoantigens in cancer immunotherapy.

21 January 2018

1 reference

Adoptive cell transfer as personalized immunotherapy for human cancer

21 January 2018

1 reference

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

21 January 2018

1 reference

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

21 January 2018

1 reference

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

21 January 2018

1 reference

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

21 January 2018

1 reference

Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients

21 January 2018

1 reference

Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells

21 January 2018

1 reference

High-throughput identification of antigen-specific TCRs by TCR gene capture

21 January 2018

1 reference

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

21 January 2018

1 reference

The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.

21 January 2018

1 reference

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

21 January 2018

1 reference

STAR: ultrafast universal RNA-seq aligner

21 January 2018

1 reference

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

21 January 2018

1 reference

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

21 January 2018

1 reference

Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads

21 January 2018

1 reference

The immune epitope database (IEDB) 3.0.

21 January 2018

1 reference

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

21 January 2018

1 reference

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.

21 January 2018

1 reference

Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity.

21 January 2018

1 reference

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

21 January 2018

1 reference

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26901407

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26901407

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.4051

1 reference

6 September 2017

0 references

1 reference